Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 45 years who are of reproductive age
- People who have a medical reason for needing a levonorgestrel-releasing intrauterine device (a hormonal IUD), such as heavy or irregular periods, painful periods, endometriosis, adenomyosis, hormone-related uterine bleeding problems, need for uterine lining protection during hormone replacement therapy, or a non-cancerous thickening of the uterine lining
- People who do not have any medical reasons that would prevent them from safely having a hormonal IUD inserted (confirm with trial site)
- People who have not used oral contraceptive pills for at least 3 months before joining
- People who had a previous IUD removed at least 1 year before joining
- People who have not taken any steroid-based anti-inflammatory medications in the 24 hours before the IUD is inserted
- People who have read and signed a consent form and agreed to take part voluntarily
Who may not be able to join:
- People who are currently pregnant or have a history of pregnancy (confirm with trial site)
- People currently using hormone therapy
- People who have a mass or growth on or near their ovaries
- People with serious ongoing health conditions, such as uncontrolled diabetes, advanced heart disease, active cancer (especially hormone-sensitive cancers), severe liver or kidney failure, or certain immune system diseases
- People with medical reasons that would make a hormonal IUD unsafe, such as a suspected pregnancy, a significant structural problem with the uterus, an active pelvic infection, severe liver disease, or a personal history of breast cancer
- People with a psychological disability
- People who do not agree to sign the consent form
- People who would not be able to attend follow-up appointments
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: havva betül bacak, md, SBÜ Gaziosmanpaşa Training and Research Hospital
Phone: +905385492848
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Ovarian Cyst Formation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.